Want to join the conversation?
$LH 2Q15 Call: SG&A was $384MM or 17.3% of revenue, a 200BP reduction compared to last years’ adjusted SG&A. The increased in SG&A was primarily due to Covance & personal cost, partially offset by Project LaunchPad savings. Excluding Covance & special charges, SG&A as percentage of revenue would have been 19%, an improvement of 30BP over last year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?